Brief: Sino Biopharmaceutical Says Second-Generation Flurbiprofen Patch Approved For Marketing
06/08/2026 12:34
BRIEF-Sino Biopharmaceutical Says Second-Generation Flurbiprofen Patch Approved For Marketing Aug 6 (Reuters) - Sino Biopharmaceutical Limited 1177.HK:
SECOND-GENERATION FLURBIPROFEN PATCH APPROVED FOR MARKETING
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit